Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Non-cash Items: 2011-2020

Historic Non-cash Items for UNITED THERAPEUTICS (UTHR) over the last 8 years, with Mar 2020 value amounting to $5.2 million.

  • UNITED THERAPEUTICS's Non-cash Items rose 34.32% to $5.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $5.2 million, marking a year-over-year increase of 34.32%. This contributed to the annual value of $90.1 million for FY2019, which is 2518.32% up from last year.
  • As of Q1 2020, UNITED THERAPEUTICS's Non-cash Items stood at $5.2 million, which was down 94.21% from $90.1 million recorded in Q4 2019.
  • Over the past 5 years, UNITED THERAPEUTICS's Non-cash Items peaked at $176.7 million during Q4 2016, and registered a low of $3.1 million during Q4 2017.
  • Moreover, its 3-year median value for Non-cash Items was $5.2 million (2020), whereas its average is $47.8 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first crashed by 98.26% in 2017, then skyrocketed by 2,518.32% in 2019.
  • UNITED THERAPEUTICS's Non-cash Items (Quarterly) stood at $176.7 million in 2016, then tumbled by 98.26% to $3.1 million in 2017, then increased by 11.62% to $3.4 million in 2018, then soared by 2,518.32% to $90.1 million in 2019, then surged by 34.32% to $5.2 million in 2020.
  • Its Non-cash Items stands at $5.2 million for Q1 2020, versus $90.1 million for Q4 2019 and $108.4 million for Q3 2019.